COMT genotype influences the effect of alcohol on blood pressure: Results from the COMBINE study

American Journal of Hypertension

Volumn 22, Issue 1, 2009, Pages 87-91

  Stewart, Scott H ^a   Oroszi, Gabor ^a   Randall, Patrick K ^a   Anton, Raymond F ^a  

^a MUSC Center for Drug and Alcohol Programs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CATECHOL METHYLTRANSFERASE; DRUGS USED IN THE TREATMENT OF ADDICTION; METHIONINE; VALINE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; ETHNICITY; FEMALE; GENE LOCUS; GENOTYPE; HUMAN; HYPERTENSION; MALE; MULTICENTER STUDY; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADULT; ALCOHOLISM; BLOOD PRESSURE; CATECHOL O-METHYLTRANSFERASE; DNA; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 57749177084     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2008.321     Document Type: Article

References (25)

1. Rehm J, Room R, Monteiro M, Gmel G, Graham K, Rehn N, Sempos CT. Alcohol as a risk factor for global burden of disease. Eur Addict Res 2003; 9:157-164.
2. Estruch R, Coca A, Rodicio JL. High blood pressure, alcohol, and cardiovascular risk. J Hypertens 2005; 23:226-229.
3. Zakhari S. Alcohol and the cardiovascular system. Molecular mechanisms for beneficial and harmful actions. Alcohol Health Res World 1997; 21:21-29.
4. Randin D, Vollenweider P, Tappy L, Jéquier E, Nicod P, Scherrer U. Suppression of alcohol-induced hypertension by dexamethasone. N Engl J Med 1995; 332:1733-1738.
5. Grassi GM, Somers VK, Renk WS, Abboud FM, Mark AL. Effects of alcohol intake on blood pressure and sympathetic nerve activity in normotensive humans: a preliminary report. J Hypertens Suppl 1989; 7:S20-S21.
6. van de Borne P, Mark AL, Montano N, Mion D, Somers VK. Effects of alcohol on sympathetic activity, hemodynamics, and chemoreflex sensitivity. Hypertension 1997; 29:1278-1283.
7. Männistö PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 1999; 51:593-628.
8. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melén K, Julkunen I, Taskinen J. Kinetics of human soluble and membrane-bound Catechol-O- methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995; 34:4202-4210.
9. 158met affects μ-opioid neurotransmitter responses to a pain stressor. Science 2003; 299:1240-1243.
10. Meyer-Lindberg A, Kohn PD, Kolachana B, Kippenhan S, McInerney-Leo A, Nussbaum R, Weinberger DR, Berman KF. Midbrain dopamine and prefrontal function in humans: Interaction and modulation by COMT genotype. Nat Neurosci 2005; 8:594-596.
11. Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE. Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 2003; 23:2008-2013.
12. Hagen K, Pettersen E, Stovner LJ, Skorpen F, Holmen J, Zwart JA. High systolic blood pressure is associated with the val/val genotype in the Catechol-O-methyltransferase gene. Am J Hypertens 2007; 20:21-26.
13. Kamide K, Kokubo Y, Yang J, Matayoshi T, Inamoto N, Takiuchi S, Horio T, Miwa Y, Yoshii M, Tomoike H, Tanaka C, Banno M, Okuda T, Kawano Y, Miyata T. Association of genetic polymorphisms of ACADSB and COMT with human hypertension. J Hypertens 2007; 25:103-110.
14. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A, for the COMBINE study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006; 295:2003-2017.
15. Stewart SH, Latham PK, Miller PM, Randall P, Anton RF. Blood pressure reduction during treatment for alcohol dependence: results from the COMBINE study. Addiction 2008; 103:1622-1628.
16. Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nature Rev Genet 2005; 6:521-532.
17. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functionalpolymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6:243-250.
18. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999; 14:143-149.
19. Shi MM, Myrand SP, Bleavins MR, de la Iglesia. FA. High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TagMan probes. Mol Pathol 1999; 52:295-299.
20. International HapMap Consortium. The International HapMap Project. Nature 2003; 426:789-796.
21. Annerbrink K, Westberg L, Nilsson S, Rosmond R, Holm G, Eriksson E. Catechol-O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men. Metabolism 2008; 57:708-711.
22. Parlesak A, Reisenauer C, Biermann J, Ratge D, Bode JC, Bode C. Reversibility of increased formation of catecholamines in patients with alcoholic liver disease. Scand J Gastroenterol 2004; 39:60-66.
23. Patkar AA, Marsden CA, Naik PC, Kendall DA, Gopalakrishnan R, Vergare MJ, Weinstein SP. Differences in peripheral noradrenergic function among actively drinking and abstinent alcohol-dependent individuals. Am J Addict 2004; 13:225-235.
24. Hall JE, Granger JP, Hall ME, Jones DW. Pathophysiology of hypertension. In Walsh RA, Simon DI, Hoit BD, Fang JC, Costa M (eds.). Hurst's the Heart, 12th edn, McGraw-Hill Companies: New York, 2008.
25. DiBona GF. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 2002; 11:197-200.